Compounds > diphenyl
Page last updated: 2024-08-18

diphenyl and Coronary Artery Disease

diphenyl has been researched along with Coronary Artery Disease in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19908 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DELLA PORTA, P; LUCCHINI, CR1
CESARI, L1
DE FELICE, D; ROSSETTO, L1
DE IASI, A1
PICCINELLI, O1
MENCI, S1
FRANZINI, C; MONTEROSSO, A; TURRI, C1
BRAT, A; GIARDINA, A; ZOLI, A1

Other Studies

8 other study(ies) available for diphenyl and Coronary Artery Disease

ArticleYear
[3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine.] (Segontin) in syndromes of coronary insufficiency. Preliminary note].
    Minerva cardioangiologica, 1961, Volume: 9

    Topics: Anti-Arrhythmia Agents; Biphenyl Compounds; Coronary Artery Disease; Coronary Disease; Humans; Prenylamine; Propylamines; Syndrome; Vasodilator Agents

1961
[Clinical observations on the use of a new synthetic agent (3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine, Segontin) in coronary insufficiency syndromes].
    Gazzetta internazionale di medicina e chirurgia, 1962, Sep-30, Volume: 66

    Topics: Biphenyl Compounds; Coronary Artery Disease; Coronary Disease; Prenylamine; Propylamines; Sympatholytics; Syndrome; Vasodilator Agents

1962
[Clinical experimentation with a new substance (3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine in syndromes caused by coronary insufficiency].
    Gazzetta internazionale di medicina e chirurgia, 1962, Sep-30, Volume: 66

    Topics: Biphenyl Compounds; Coronary Artery Disease; Coronary Disease; Propylamines; Sympatholytics; Syndrome; Vasodilator Agents

1962
[Clinical and electrocardiographic considerations on the use of a new synthesis (phenyl-propyl-diphenyl-propyl-amine) in the therapy of syndromes of coronary insufficiency in urologic patients].
    Minerva medica, 1963, Apr-25, Volume: 54

    Topics: Biphenyl Compounds; Coronary Artery Disease; Coronary Disease; Electrocardiography; Humans; Prenylamine; Syndrome; Urology

1963
[N-(1-Methyl-2-phenylethyl)-3,3-diphenyl-propylamine, a new synthetic substance for the treatment, from the etiopathogenic viewpoint, of myocardiopathies caused by coronary insufficiency].
    Il Farmaco; edizione pratica, 1961, Volume: 16

    Topics: Biphenyl Compounds; Cardiomyopathies; Coronary Artery Disease; Coronary Disease; Phenethylamines; Propylamines; Vasodilator Agents

1961
[CLINICO-ELECTROCARDIOGRAPHIC OBSERVATIONS ON THE ACTIVITY OF N-(3)-PHENYLPROPYL-(2)-1,1-DIPHENYL-PROPYL-(3)-AMINE (F.P.D.P.A.) IN CORONARY INSUFFICIENCY].
    Gazzetta internazionale di medicina e chirurgia, 1964, Jan-15, Volume: 68

    Topics: Biomedical Research; Biphenyl Compounds; Coronary Artery Disease; Coronary Disease; Electrocardiography; Humans; Prenylamine

1964
[PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE (SEGONTIN) IN TREATMENT OF SYNDROMES DUE TO CORONARY INSUFFICIENCY IN PATIENTS OVER SEVENTY].
    Minerva cardioangiologica, 1964, Volume: 12

    Topics: Amines; Biphenyl Compounds; Coronary Artery Disease; Coronary Disease; Drug Therapy; Geriatrics; Humans; Prenylamine; Syndrome; Toxicology

1964
[METABOLIC EFFECTS OF PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE IN THE HEALTHY MAN AND IN THE PATIENT WITH ISCHEMIC HEART DISEASE. I. CLINICAL AND EXPERIMENTAL PHARMACOLOGY OF FEDIPRA].
    Rivista critica di clinica medica, 1963, Volume: 63

    Topics: Biphenyl Compounds; Coronary Artery Disease; Coronary Disease; Myocardial Ischemia; Pharmacology; Prenylamine; Toxicology

1963